2021
DOI: 10.1101/2021.06.30.450488
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Glycomic profiling of the gut microbiota by Glycan-seq

Abstract: Background: There has been immense interest in studying the relationship between the gut microbiota and human health. Bacterial glycans modulate the cross talk between the gut microbiota and its host. However, little is known about these glycans because of the lack of appropriate technology to study them. Methods: We previously developed a sequencing-based glycan profiling method called Glycan-seq, which is based on the use of 39 DNA-barcoded lectins. In this study, we applied this technology to analyze the gl… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 38 publications
0
2
0
Order By: Relevance
“…We envision a pipeline in which this explainable DL approach is used to analyze data generated by SUGAR-seq or similar technologies, to decode the biology of less well-studied glycoforms (e.g., high-mannose glycans, sulfated glycans, and I-branched glycans) and their importance in disease ( Chuzel et al., 2021 ; Dimitroff, 2019 ; de Leoz et al., 2011 ; Loke et al., 2016 ; Sun et al., 2022 ). For this, future work needs to expand the capabilities of the associated lectin-seq, similar to the already reported Glycan-seq technology ( Oinam et al., 2021 ). We also anticipate the integration of more data modalities besides transcriptomes.…”
Section: Discussionmentioning
confidence: 99%
“…We envision a pipeline in which this explainable DL approach is used to analyze data generated by SUGAR-seq or similar technologies, to decode the biology of less well-studied glycoforms (e.g., high-mannose glycans, sulfated glycans, and I-branched glycans) and their importance in disease ( Chuzel et al., 2021 ; Dimitroff, 2019 ; de Leoz et al., 2011 ; Loke et al., 2016 ; Sun et al., 2022 ). For this, future work needs to expand the capabilities of the associated lectin-seq, similar to the already reported Glycan-seq technology ( Oinam et al., 2021 ). We also anticipate the integration of more data modalities besides transcriptomes.…”
Section: Discussionmentioning
confidence: 99%
“…We envision a pipeline in which this explainable DL approach is used to analyze data generated by SUGAR-seq or similar technologies, to decode the biology of less well-studied glycoforms (e.g., high-mannose glycans, sulfated glycans, I-branched glycans) and their importance in disease (Chuzel et al, 2021; Dimitroff, 2019; de Leoz et al, 2011; Loke et al, 2016; Sun et al, 2022). For this, future work needs to expand the capabilities of the associated lectin-seq, similar to the already reported Glycan-seq technology (Oinam et al, 2021). We also anticipate the integration of more data modalities besides transcriptomes.…”
Section: Discussionmentioning
confidence: 99%